BATM has unveiled a molecular diagnostics kit that utilises a self-collected saliva specimen to test for SARS-CoV-2 (Covid-19).

Compared to present swabbing methods, the saliva-based RT-PCR test can enhance the sample collection process and turnaround time while ensuring diagnostic accuracy.

The new kit is part of Adaltis’s MOLgen product range, and is comprised of reagents developed to precisely identify SARS-CoV-2 in a saliva specimen collected by a person chewing a cotton ball for 30 seconds and then spitting it (or spitting directly) into a small plastic collector tube (Salivette).

It ensures the highest levels of diagnostic accuracy using the RT-PCR technique versus other saliva-based tests presently available in the market that mainly use the lateral flow method. It can be less precise producing false negatives and positives.

The latest kits’ reagents are based on the group’s present Covid-19 antigen kit that tests specimen obtained by swabbing the upper and middle parts of the throat or fluid from the lungs.

In addition, it has five gene discovery capability to aid in identifying even with a reduced viral load and 100% accuracy for specificity and sensitivity.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

As people can self-collect a saliva sample, the test can be carried out without requiring any trained healthcare staffs in full-body personal protective equipment.

As the test is non-invasive, it has particular benefits for children and individuals with disabilities.

Furthermore, processing times at the lab are significantly shorter as the test does not require expensive RNA extraction, which is a major reason for contaminations that cause false diagnoses.

This CE-certified kit can also detect all-known Covid-19 variants, including asymptomatic individuals.

BATM CEO Dr Zvi Marom said: “We are extremely proud to have launched this new saliva-based Covid-19 test for samples that are self-collected without the need for swabbing.

“This greatly simplifies the testing process to increase speed and reduce cost while maintaining the same high level of diagnostic accuracy.”